Author: American Association for Cancer ResearchPublisher:
ISBN: 9781734743265
Category :
Languages : en
Pages :
Book Description
AACR Cancer Progress Report 2021
Author: American Association for Cancer ResearchPublisher:
ISBN: 9781734743265
Category :
Languages : en
Pages :
Book Description
AACR Cancer Progress Report 2023
Author: American Association for Cancer ResearchPublisher:
ISBN:
Category :
Languages : en
Pages : 0
Book Description
Unprecedented progress in medical research is increasing our understanding of the collection of diseases we call cancer and is driving improvements in cancer prevention, early detection, diagnosis, and treatment. These advances are made possible by investments in NIH, NCI, FDA, and CDC by the U.S. federal government. As the first and largest professional organization in the world dedicated to preventing and curing all cancers, AACR continues to be a catalyst for scientific breakthroughs that save the lives of patients with cancer. AACR is committed to increasing public understanding of cancer and advocating for increased funding for medical research.The annual AACR Cancer Progress Report to Congress and the American public is a cornerstone of AACR's educational efforts. This thirteenth edition of the report highlights how research continues to extend and improve the lives of Americans, including the lives of the eight courageous individuals featured in the report and their family members who have shared their experiences with cancer. It also underscores how unwavering, bipartisan support from Congress, in the form of robust and sustained annual increases in funding for NIH, NCI, FDA, and CDC, is urgently needed.The remarkable progress being made against cancer is resulting in a steady reduction in cancer death rates, and a consistent rise in the number of people who live longer and fuller lives after a cancer diagnosis. In fact, the overall U.S. cancer death rate has fallen by 33 percent between 1991 and 2020, a reduction that translates into averting an estimated 3.8 million deaths from cancer. The reduction in overall cancer mortality is driven largely by the decline in the U.S. lung cancer death rate, the pace of which has accelerated in recent years because of reduction in smoking and advances in early detection and treatment. Additionally, the reduction in death rates for melanoma, colorectal cancer, prostate cancer, and female breast cancer has contributed to the progress against overall U.S. cancer mortality. Notably, among U.S. children and adolescents, overall cancer death rates have declined by 70 percent and 64 percent, respectively, over the past five decades.
AACR Cancer Progress Report 2022
Author: American Association for Cancer ResearchPublisher:
ISBN:
Category :
Languages : en
Pages : 0
Book Description
Transformative research and technological innovations are driving unprecedented progress against the collection of diseases we call cancer. As the first and largest professional organization in the world dedicated to advancing all areas of cancer research and patient care, AACR has been and continues to be a catalyst for scientific breakthroughs that save and enhance the lives of cancer patients. It is also committed to increasing public understanding of cancer and advocating for increased federal funding for cancer research and related sciences. The annual AACR Cancer Progress Report to Congress and the American public is a cornerstone of AACR's educational efforts. This twelfth edition of the report highlights how research continues to extend and improve lives, including the lives of the five courageous individuals featured in the report and their family members who have shared their experiences with cancer. It also underscores how unwavering, bipartisan support from Congress, in the form of robust and sustained annual increases in funding for NIH, NCI, CDC, and FDA, is urgently needed if we are to realize our vision of eradicating cancer for all populations. The remarkable progress being made against cancer-in particular, improvements in reducing smoking rates and developments in early detection and treatment-is resulting in a steady fall in cancer death rates, and a consistent rise in the number of people who live longer after a cancer diagnosis. In fact, in the United States, the age-adjusted overall cancer death rate has been declining since the 1990s, with the reductions between 1991 and 2019 translating into nearly 3.5 million cancer deaths avoided. Additionally, the number of cancer survivors living in the United States has exceeded 18 million as of January 1, 2022. Unfortunately, certain U.S. populations, including racial and ethnic minorities and several other medically underserved groups, have not benefited equally from the advances against cancer. Complex factors referred to as social determinants of health have contributed to cancer health disparities in the United States. It is imperative that all stakeholders work together to eradicate the systemic and structural injustices that are current barriers.
AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care
Author: American Association for Cancer ResearchPublisher:
ISBN: 9781734743296
Category :
Languages : en
Pages :
Book Description
Highlights of Progress in Research on Cancer
Author: AACR Cancer Progress Report 2020
Author: American Association for Cancer ResearchPublisher:
ISBN: 9781734743234
Category :
Languages : en
Pages :
Book Description
The annual AACR Cancer Progress Report to Congress and the American public is a cornerstone of the AACR's educational and advocacy efforts. This tenth edition of the report highlights how research continues to extend and improve lives, like the lives of the courageous individuals featured in the report who have shared their experiences with cancer. It also underscores how the COVID-19 pandemic has negatively affected cancer science and medicine, as well as how unwavering, bipartisan support from Congress, in the form of robust and sustained annual increases in funding for the NIH, NCI, and FDA, is vital if we are to accelerate the pace of progress against cancer for the benefit of families everywhere.
AACR Cancer Disparities Progress Report 2022
Author: American Association for Cancer ResearchPublisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Launched in 2020, the AACR Cancer Disparities Progress Report 2020 to Congress and the American public is a cornerstone of the AACR's educational and advocacy efforts to achieve health equity. This second edition of the report highlights areas of recent progress in reducing cancer health disparities. It also emphasizes the vital need for continued transformative research and for increased collaborations if we are to ensure that advances against cancer benefit all patients, regardless of their race, ethnicity, age, sexual orientation, gender identity, socioeconomic status, or geographic location.
AACR Cancer Disparities Progress Report 2020
Author: American Association for Cancer ResearchPublisher:
ISBN: 9781734743203
Category :
Languages : en
Pages :
Book Description
Cancer health disparities are one of the most pressing public health challenges we face today in the United States, and the AACR Cancer Disparities Progress Report 2020 highlights areas of progress in addressing this challenge. It also emphasizes the need for continued research and for increased collaboration among stakeholders if we are to achieve the bold vision of health equity. Racial and ethnic minorities are among the populations groups that have long experienced significant cancer health disparities, although progress in the form of narrowing of the disparities in the overall cancer death rate among racial and ethnic groups in the United States is evident in recent years. We have also made progress in deepening our understanding of the many complex factors that contribute to cancer health disparities. Most important among these are social, clinical, behavioral, cultural, psychological, environmental, and genetic and biological factors. Unfortunately, as pointed out in the report, most data on cancer biology comes from white individuals and there is an urgent need for much more research to increase our understanding of the genes and mutations associated with cancer in racial and ethnic minorities.Despite recent advances in cancer treatment, racial and ethnic minorities are often less likely to receive the standard of care recommended for the type and stage of cancer with which they have been diagnosed. To achieve health equity for everyone, stakeholders must work together to remove the barriers that prevent all segments of the population benefiting equally from lifesaving progress in cancer treatment, including a serious lack of racial and ethnic diversity among those who pariticipate in cancer clinical trials. Over the past decade, the field of cancer health disparities research has evolved from simply describing different outcomes among populations into an established multidisciplinary field of research. To further accelerate the pace of progress against cancer health disparities concerted efforts by all stakeholders is absolutely critical. Thus, the report concludes with a call to action to Congress. Through robust and sustained funding, Congress help us achieve the bold vision of health equity.
Anglo-American Cataloguing Rules
Author: Publisher:
ISBN: 9780838935453
Category : Descriptive cataloging
Languages : en
Pages :
Book Description
The Philadelphia Chromosome: A Genetic Mystery, a Lethal Cancer, and the Improbable Invention of a Lifesaving Treatment
Author: Jessica WapnerPublisher: The Experiment, LLC
ISBN: 1615191658
Category : Health & Fitness
Languages : en
Pages : 345
Book Description
One of The Wall Street Journal’s 10 Best Nonfiction Books of the Year Philadelphia, 1959: A scientist scrutinizing a single human cell under a microscope detects a missing piece of DNA. That scientist, David Hungerford, had no way of knowing that he had stumbled upon the starting point of modern cancer research— the Philadelphia chromosome. It would take doctors and researchers around the world more than three decades to unravel the implications of this landmark discovery. In 1990, the Philadelphia chromosome was recognized as the sole cause of a deadly blood cancer, chronic myeloid leukemia, or CML. Cancer research would never be the same. Science journalist Jessica Wapner reconstructs more than forty years of crucial breakthroughs, clearly explains the science behind them, and pays tribute—with extensive original reporting, including more than thirty-five interviews—to the dozens of researchers, doctors, and patients with a direct role in this inspirational story. Their curiosity and determination would ultimately lead to a lifesaving treatment unlike anything before it. The Philadelphia Chromosome chronicles the remarkable change of fortune for the more than 70,000 people worldwide who are diagnosed with CML each year. It is a celebration of a rare triumph in the battle against cancer and a blueprint for future research, as doctors and scientists race to uncover and treat the genetic roots of a wide range of cancers.